8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group. (September 2015) - Dearnaley, D.; Syndikus, I.; Mossop, H.; Birtle, A.; Bloomfield, D.; Cruickshank, C.; Graham, J.; Hassan, S.; Khoo, V.; Logue, J.; Mayles, H.; Money-Kyrle, J.; et al.